Terms: = Sarcomas AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
126 results:
1. Circ_0002669 promotes osteosarcoma tumorigenesis through directly binding to MYCBP and sponging miR-889-3p.
Zhang Y; Zhan Y; Liu Z; Guo H; Liu D; Chen C
Biol Direct; 2024 Apr; 19(1):25. PubMed ID: 38570856
[TBL] [Abstract] [Full Text] [Related]
2. Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus/rapidly accelerated fibrosarcoma 1 pathway.
Zhu T; Zhou P; Yang L; Fang X; Zhi X
Environ Toxicol; 2024 Apr; 39(4):2064-2076. PubMed ID: 38095131
[TBL] [Abstract] [Full Text] [Related]
3. Identification of hub genes and pathways associated with cellular senescence in diabetic foot ulcers via comprehensive transcriptome analysis.
Huang Y; Wang D; Zhang W; Yuan X; Li K; Zhang Y; Zeng M
J Cell Mol Med; 2024 Jan; 28(1):e18043. PubMed ID: 37985432
[TBL] [Abstract] [Full Text] [Related]
4. Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.
Suppiah S; Mansouri S; Mamatjan Y; Liu JC; Bhunia MM; Patil V; Rath P; Mehani B; Heir P; Bunda S; Velez-Reyes GL; Singh O; Ijad N; Pirouzmand N; Dalcourt T; Meng Y; Karimi S; Wei Q; Nassiri F; Pugh TJ; Bader GD; Aldape KD; Largaespada DA; Zadeh G
Nat Commun; 2023 May; 14(1):2696. PubMed ID: 37164978
[TBL] [Abstract] [Full Text] [Related]
5. Integrative analyses of bulk microarray data to discover genes, pathways, and immune infiltration characteristics associated with targeting of Ewing sarcoma.
Cao B; Sun H; Fan Z; Khawar MB; Cai L; Yu S; Liang Z; Lv D; Wang N; Bi C; Sun H
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6967-6977. PubMed ID: 36849756
[TBL] [Abstract] [Full Text] [Related]
6. Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang N; Zhang Y; Guo S; Chen R; Kong F; Wang S; Yuan M; Chen R; Shen D; Wang J
Cancer Res Treat; 2023 Jul; 55(3):978-991. PubMed ID: 36731460
[TBL] [Abstract] [Full Text] [Related]
7. Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities.
Dorai S; Alex Anand D
Cells; 2022 Nov; 11(23):. PubMed ID: 36497125
[TBL] [Abstract] [Full Text] [Related]
8. Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.
Schaefer IM; Hemming ML; Lundberg MZ; Serrata MP; Goldaracena I; Liu N; Yin P; Paulo JA; Gygi SP; George S; Morgan JA; Bertagnolli MM; Sicinska ET; Chu C; Zheng S; Mariño-Enríquez A; Hornick JL; Raut CP; Ou WB; Demetri GD; Saka SK; Fletcher JA
Br J Cancer; 2022 Nov; 127(11):2072-2085. PubMed ID: 36175617
[TBL] [Abstract] [Full Text] [Related]
9. Histiocytic Sarcoma With ccnd1 Gene Rearrangement Clonally Related and Transdifferentiated From Mantle Cell Lymphoma.
Kumar J; Al-Kawaaz M; Martin BA; Hegazi MM; Tan B; Gratzinger D
Am J Clin Pathol; 2022 Oct; 158(4):449-455. PubMed ID: 35964234
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Characteristics, Prognostic Factor and a Novel Dynamic Prediction Model for Overall Survival of Elderly Patients With Chondrosarcoma: A Population-Based Study.
Tong Y; Cui Y; Jiang L; Pi Y; Gong Y; Zhao D
Front Public Health; 2022; 10():901680. PubMed ID: 35844853
[TBL] [Abstract] [Full Text] [Related]
11. Super enhancers define regulatory subtypes and cell identity in neuroblastoma.
Gartlgruber M; Sharma AK; Quintero A; Dreidax D; Jansky S; Park YG; Kreth S; Meder J; Doncevic D; Saary P; Toprak UH; Ishaque N; Afanasyeva E; Wecht E; Koster J; Versteeg R; Grünewald TGP; Jones DTW; Pfister SM; Henrich KO; van Nes J; Herrmann C; Westermann F
Nat Cancer; 2021 Jan; 2(1):114-128. PubMed ID: 35121888
[TBL] [Abstract] [Full Text] [Related]
12. Response to neoadjuvant chemotherapy and survival of children and adolescents with high-grade osteosarcoma treated based on the EURAMOS-1 protocol.
Suárez-Mattos A; Arroyave F; Infante AM; Narváez C; Soto C; Gómez L; Amaya-Nieto J
Bol Med Hosp Infant Mex; 2022; 79(1):17-25. PubMed ID: 35086129
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.
Kobayashi Y; Kitazono I; Akahane T; Yanazume S; Kamio M; Togami S; Nohara S; Sakamoto I; Yokoyama S; Tabata K; Kobayashi H; Tanimoto A
Pathol Oncol Res; 2021; 27():1610013. PubMed ID: 35002543
[TBL] [Abstract] [Full Text] [Related]
14. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
15. Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.
Travaglino A; Raffone A; Raimondo D; Arciuolo D; Angelico G; Valente M; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Santoro A; Seracchioli R; Franco Zannoni G
Int J Gynaecol Obstet; 2022 Jul; 158(1):13-20. PubMed ID: 34536971
[TBL] [Abstract] [Full Text] [Related]
16. Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus.
Valenciaga A; Iwenofu OH; Tinoco G
J Natl Compr Canc Netw; 2021 Jul; 19(7):775-779. PubMed ID: 34340207
[TBL] [Abstract] [Full Text] [Related]
17. Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature.
Koelsche C; Benhamida JK; Kommoss FKF; Stichel D; Jones DTW; Pfister SM; Heilig CE; Fröhling S; Stenzinger A; Buslei R; Mentzel T; Baumhoer D; Ladanyi M; Antonescu CR; Flucke U; Gorp JV; Bode-Lesniewska B; Deimling AV; Mechtersheimer G
Mod Pathol; 2021 Dec; 34(12):2122-2129. PubMed ID: 34312479
[TBL] [Abstract] [Full Text] [Related]
18. Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy.
Kawashima I; Oishi N; Kasai K; Inoue T; Hosokawa E; Nakadate A; Matsuura M; Kumagai T; Koshiishi M; Yamamoto T; Nakajima K; Tanaka M; Kondo T; Kirito K
Virchows Arch; 2022 May; 480(5):1101-1105. PubMed ID: 34226971
[TBL] [Abstract] [Full Text] [Related]
19. Systematic review of charged-particle therapy for chordomas and sarcomas of the mobile spine and sacrum.
Pennington Z; Ehresman J; Elsamadicy AA; Shin JH; Goodwin CR; Schwab JH; Sciubba DM
Neurosurg Focus; 2021 May; 50(5):E17. PubMed ID: 33932924
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic impact of KRAS mutation status for patients with stage IV adenocarcinoma of the lung treated with first-line pembrolizumab monotherapy.
Noordhof AL; Damhuis RAM; Hendriks LEL; de Langen AJ; Timens W; Venmans BJW; van Geffen WH
Lung Cancer; 2021 May; 155():163-169. PubMed ID: 33838467
[TBL] [Abstract] [Full Text] [Related]
[Next]
